Clinical trial
A Single-arm, Prospective, Single-center Clinical Study on Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen
NCT07137039 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-arm, Prospective, Single-center Clinical Study on Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen
- Lead sponsor
- The First Affiliated Hospital of Xiamen University
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- August 20, 2025
- Completion date
- August 20, 2028
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced hypopharyngeal cancer